Home GlycoEra

GlycoEra

In operation
Series B
Novel Biologics Developer
Basic
Enterprise Profile

Basic Information

GlycoEra is a biotechnology company based in Switzerland that has developed a game-changing glycan engineering platform to build a pipeline of high-value novel biologics to address unmet medical needs. GlycoEra's CustomGlycan platform unlocks unique biological pathways by rationally engineering glycan structures and glycosylation sites on specific protein targets, overcoming the limitations and complexities of controlling glycosylation.
GlycoEra AG
Zurich,Zurich,Switzerland
101~500 people
January 01, 2020
--

Enterprise Profile

Industrial Sector
New Drug Development Scientific Research and Experimental Development Services
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs